Welcome to the May issue of ACM Capital Partners’ Value Line newsletter. In this issue you will find details of three new engagements – a quality of earnings review and subsequent interim assignment for a fast growing internet based consumer products company; the implementation of Phase II of an operational assignment for a medical engineering company; and an interim President and CEO role for a $40M medical company.
ACM COMPLETES A QUALITY OF EARNINGS REPORT FOR A CONSUMER PRODUCTS COMPANY
The firm was retained by a private equity client to assist with a quality of earnings report on an acquisition target in March. Despite the lack of adequate financial reporting and limited access to the senior management; our professional was able to quickly step in and provide earnings and EBITDA support as well as identify inherent financial weaknesses with the accounting systems in place. Despite these issues, we were able to provide a thorough report to the equity sponsor and the acquisition was completed in late May.
As part of the post-closing transition, the equity sponsor retained ACM to provide treasury and reporting support until a permanent solution was found. “This is a great example of our value proposition to our equity sponsors and debt clients,” said Jim Martin, Managing Partner. “This consumer products business is enjoying a nice growth trajectory with substantial profitability. Like many in their position though, they have outgrown the infrastructure they initially established. Our professional that performed the quality of earnings transitioned the assignment at closing to one of our most established financial managers who has stepped in to address the issues.”
ACM RETAINED TO COMPLETE PHASE II OF AN OPERATIONAL ASSESSMENT FOR $20M MEDICAL ENGINEERING FIRM
The firm was retained by a Florida based medical engineering firm to perform an operational assessment, which included a report of our findings. Based on the Phase I, the owners of the firm hired ACM as their interim CRO to assist with the implementation of the Phase I recommendations.
“Given our extensive experience in this space and time invested onsite at the client’s business, the transition to Phase II was both natural and seamless,” said Kevin Henry, Director of Business Development at ACM. “We continue to execute in these engagements. Our clients like the fact that we align our fees with achievable results.”
ACM HIRED AS INTERIM CEO FOR A $40M MEDICAL COMPANY
The firm announced it has been retained to serve as the interim CEO for a medical company located on the East Coast. The focus of the assignment includes a redesign of the corporate strategy, including new customer acquisitions, together with revamping its foreign operations. “We are excited to continue to assist this client at this critical period of its life cycle,” said Jim Martin.
